双极电凝联合1%聚桂醇泡沫硬化剂治疗16例舌微囊型淋巴管畸形疗效观察  

Evaluation of the effectiveness of treatment of 16 patients with tongue microcystic lymphatic malformation using bipolar coagulation forceps combined with 1% lauromacrogol foam sclerotherapy

作　　者：李嘉朋[1] 张国润 陈巨峰[1] 李金[1] 刘士维 贺先明 冼淡[1] LI Jia-peng;ZHANG Guo-run;CHEN Ju-feng;LI Jin;LIU Shi-wei;HE Xian-ming;XIAN Dan(Center of Stomatology,First People’s Hospital of Foshan,Foshan 528000,Guangdong Province,China)

机构地区：[1]佛山市第一人民医院口腔医学中心,广东佛山528000

出　　处：《上海口腔医学》2021年第4期444-448,共5页Shanghai Journal of Stomatology

摘　　要：目的:评价双极电凝联合1%聚桂醇泡沫硬化剂治疗舌微囊型淋巴管畸形的临床疗效及安全性。方法:回顾分析2017年4月—2020年4月佛山市第一人民医院口腔科收治的16例舌微囊型淋巴管畸形患者的临床资料,男7例,女9例,年龄15个月~21岁,平均(8.32±1.21)岁,对治疗效果和并发症进行分析。结果:16例患者全部随访6~12个月。疗效评价为Ⅳ级11例(68.75%),Ⅲ级3例(18.75%),Ⅱ级2例(12.5%),Ⅰ级0例,有效率87.5%。1例出现舌黏膜、舌肌坏死。结论:双极电凝联合1%聚桂醇泡沫硬化剂治疗舌微囊型淋巴管畸形是一种微创、安全、有效的治疗方法。PURPOSE: To investigate the clinical efficacy and safety of bipolar coagulation forceps combined with 1%lauromacrogol foam sclerotherapy in the treatment of microcystic lymphatic malformation of tongue. METHODS: The clinical data of 16 patients with microcystic lymphatic malformation of the tongue admitted to the Department of Stomatology of Foshan First People’s Hospital from April 2017 to April 2020 were retrospectively analyzed, including 7 males and 9 females, aging from 15 months to 21 years. The average age of patients was 8.32±1.21 years. The efficacy and complications of the patients were evaluated. RESULTS: All 16 patients were followed up for 6 to 12 months. The clinical response was evaluated as eleven patients(68.75%) for grade Ⅳ, three(18.75%) for grade Ⅲ, two(12.5%) for grade Ⅱ, and the effective rate was 87.5%. Necrosis of tongue mucosa and muscle occurred in 1 patient. CONCLUSION S: Bipolar coagulation forceps combined with 1% lauromacrogol foam sclerotherapy is a minimally invasive, safe and effective treatment for tongue microcystic lymphatic malformation.

关 键 词：舌 微囊型淋巴管畸形 双极电凝 聚桂醇泡沫硬化剂 

分 类 号：R782.2[医药卫生—口腔医学]